Table 5.
Analysis of methylated CpG sites for hsa-miR-148a and hsa-miR-152 in HIV-positive vs. negative primary tumors
| HIV + | HIV - | |
|---|---|---|
| Hsa-miR-148a | ||
| Total CpG islands | 4 | 4 |
| Methylated CpG | 4 | 0 |
| Unmethylated CpG | 0 | 4 |
| Hsa-miR-152 | ||
| Total CpG islands | 30 | 30 |
| Methylated CpG | 25 | 11 |
| Unmethylated CpG | 5 | 19 |